Navigation Links
Fink receives Gruber Genetics Prize, lectures at American Society of Human Genetics annual meeting
Date:11/2/2010

November 4, New York, NY No one knows better "The Promise of Human Genetics" than the man who will address that topic at a conference in Washington D.C. on Wednesday: this year's Gruber Genetics Prize recipient Prof. Gerald R. Fink.

It is Fink who discovered how to "grow" genes in yeast, thus allowing scientists to create and study a never‐ending series of DNA scenarios and track how cells inherit information. It is Fink whose "transforming" technique effectively opened a biological factory to produce insulin, vaccines and other medical products. It is Fink and his colleagues who discerned the genetic mechanisms by which certain disease‐bearing fungi switch from benign to infectious, thereby setting the stage for an unprecedented defense of the immune system. And it is Fink who has generously shared his work with other scientists and who continues to teach the next generation of researchers.

He will deliver the Gruber Lecture at the annual meeting of the American Society of Human Genetics, immediately after accepting the $500,000 Genetics Prize from The Peter and Patricia Gruber Foundation.

The son of a medical doctor, Fink was born in New York 70 years ago. He majored in biology at Amherst College and earned his PhD in genetics from Yale University. He taught at Cornell University for 15 years before moving to the Massachusetts Institute of Technology in 1982, where he continues to research and teach. He is also associated with the Whitehead Institute for Biomedical Research.

Additional Information:

The official citation to the Prize reads: The Peter and Patricia Gruber Foundation proudly presents the 2010 Genetics Prize to Gerald R. Fink, Ph.D., a founder of modern yeast genetics and a leader in the use of model‐organism genetics to study diverse biological problems. Fink developed a system that allows insertions of laboratory‐modified‐DNA molecules into their natural locations in the
'/>"/>

Contact: Alyson O'Mahoney
aomahoney@robinleedyassociates.com
914-241-0086
Robin Leedy & Associates, Inc.
Source:Eurekalert

Page: 1 2

Related biology news :

1. U of I receives $1.5 million to further sustainability in ornamental crop production
2. La Jolla Institute scientist Klaus Ley receives Malpighi award
3. BMC receives National Institutes of Health grant to study intrauterine cocaine and substance reslience
4. Virginia Techs Mueller receives friendship award from China
5. Aeras-led research consortium receives FDA support
6. UNC scientist receives NIH directors New Innovator Award
7. RIT receives federal grant to construct new sustainability research facility
8. UCLA receives $12.5M to lead international project to study proteins implicated in heart disease
9. Einstein receives $30 million to study protein form and function
10. Prof. Xiaoguang Meng receives honorary master of engineering from Stevens
11. LSU receives $15 million grant from NIH to build biomedical research pipeline for Louisiana
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... cell, including sperm, bacteria and algae, propel themselves ... about one-hundredth of a millimetre long, function like ... shorter structures called cilia are found on the ... such as moving liquids over the cell. ... transport mucus and expel pathogens from our airways, ...
(Date:7/28/2014)... An international team of researchers led by the University ... rice. , The genetic information will enhance scientists, and ... as well as enable the development of new rice ... environmental stressors to help solve global hunger challenges. , ... Oryza glaberrima ) and evidence for independent domestication," was ...
(Date:7/28/2014)... rat brain cells suggests that the effects of a ... cells are temporary. , The study, published in this ... was conducted by biologists at the University of California, ... York in response to concerns, arising from multiple studies ... to general anesthetics may increase their susceptibility to long-term ...
Breaking Biology News(10 mins):Microscopic rowing -- without a cox 2Microscopic rowing -- without a cox 3Generating a genome to feed the world: UA-led team sequences African rice 2Generating a genome to feed the world: UA-led team sequences African rice 3Generating a genome to feed the world: UA-led team sequences African rice 4Study suggests disruptive effects of anesthesia on brain cell connections are temporary 2Study suggests disruptive effects of anesthesia on brain cell connections are temporary 3
... cancer has shown considerable promise in early clinical trials ... drugs. Chemists and biologists at ... Sloan-Kettering Cancer Center, have created a new drug to ... as castration-resistant prostate cancer, or CRPC. Also referred to ...
... of drug-resistant bacteria, called multidrug-resistant gram-negative (MDRGN) ... common antimicrobial-resistant infections in long-term care facilities, ... at Hebrew SeniorLife,s Institute for Aging Research., ... of the main reservoirs of antimicrobial-resistant bacteria. ...
... /PRNewswire-Asia/ -- Futronic Technology Company,Limited, a global provider of ... of FS90 USB2.0 Mini Fingerprint,Scanner. , ... deliver high quality image,in a very small form factor. ... and just,slightly larger than one half of Futronic FS80 ...
Cached Biology News:New drug shows promise in treating drug-resistant prostate cancer 2New drug shows promise in treating drug-resistant prostate cancer 3New drug shows promise in treating drug-resistant prostate cancer 4Study finds multidrug-resistant gram-negative bacteria high in long-term care 2Futronic Launches FS90 USB2.0 Mini Fingerprint Scanner 2
(Date:7/29/2014)... Cheshire Cat: Can a particle be separated from its ... Communications , published the results of the first Cheshire ... conducted by Chapman University in Orange, CA, and Vienna ... a cat without a grin," thought Alice in Wonderland, ... curious thing I ever saw in my life!" Alice,s ...
(Date:7/29/2014)... YORK , July 29, 2014  Pomerantz LLP ... Laboratories, Inc. ("Impax" or the "Company") (NASDAQ: IPXL).  Such ... at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. ... of its officers and/or directors have violated Sections 10(b) ... On July 29, 2014, Impax Laboratories, ...
(Date:7/29/2014)... Calif. , July 29, 2014 /PRNewswire-iReach/ -- ... agreement with FORMA Therapeutics, Inc., to provide access ... proprietary fragment-based lead discovery platform for novel small ... excited about the opportunity to work with FORMA ... of epigenetics and protein homeostasis. FORMA Therapeutics, decision ...
(Date:7/29/2014)... TransVac Solutions, the trusted leader in ... solutions for hospitals, will be exhibiting at booth #209 ... Conference & Technical Exhibition Aug. 3-6 in Chicago, Ill. ... making hospitals cleaner, reducing infection risk and saving millions ... cycle. Staff will be available at booth #209 ...
Breaking Biology Technology:The quantum Cheshire cat: Scientists separate a particle from its properties 2The quantum Cheshire cat: Scientists separate a particle from its properties 3The quantum Cheshire cat: Scientists separate a particle from its properties 4SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Impax Laboratories, Inc. - IPXL 2Nanosyn Announces Expanded Partnership With FORMA Therapeutics 2TransVac Presents Cost Saving Technology at ASHE Conference for Keeping Hospitals Cleaner 2
... DJO Incorporated,(NYSE: DJO ), a global provider of ... reported that on August 9, 2007,the U.S. Federal Trade ... the Hart-Scott-Rodino Antitrust Improvements Act of,1976, as amended, for ... Therapeutics, Inc. ("ReAble"). On July 16, 2007, DJO ...
... Valeant Pharmaceuticals ... ... Biosciences,Inc. (Pink Sheets: ARDC) today announced that it has received the ... (NYSE: VRX ). In December 2006, Ardea Biosciences entered ...
... Shareholder Support for Vermed Sale, SAN DIEGO, Aug. ... innovator and leader of,impedance cardiography (ICG) technology, today announced ... progressing well with over 50%,of the necessary shareholder votes ... the Vermed sale. The ratio of votes,received is running ...
Cached Biology Technology:DJO Incorporated's Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review 2DJO Incorporated's Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review 3DJO Incorporated's Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review 4Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc. 2CardioDynamics Provides 2007 Shareholder Meeting Update 2CardioDynamics Provides 2007 Shareholder Meeting Update 3
HOXC11 Antibody...
Anti-NeuroD 6 Immunogen: Synthetic peptide. Available Date: 36708...
HOXC11 Antibody...
Anti-MMP-14, catalytic domain, clone LEM-2/15.8 Immunogen: Synthetic peptide: amino acid sequence 218-233 within the catalytic domain Available Date: 38579...
Biology Products: